Stockreport

Dermira up 29% on additional mid-stage data on dermatitis med lebrikizumab [Seeking Alpha]

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com
PDF Seeking Alpha Healthcare | On the Move Dermira up 29% on additional mid-stage data on dermatitis med lebrikizumab Oct. 18, 2019 11:11 AM ET Dermira, Inc. (DERM) Douglas [Read more]